Arrowstreet Capital Limited Partnership Sells 15,213 Shares of Itron, Inc. $ITRI

Arrowstreet Capital Limited Partnership lowered its position in shares of Itron, Inc. (NASDAQ:ITRI) by 3.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 424,214 shares of the scientific and technical instruments company’s stock after selling 15,213 shares during the quarter. Arrowstreet Capital Limited Partnership owned about 0.93% of Itron worth $55,839,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Impax Asset Management Group plc bought a new stake in shares of Itron during the 2nd quarter valued at about $91,998,000. Norges Bank acquired a new position in Itron in the second quarter valued at approximately $71,727,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Itron by 129.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company’s stock worth $76,713,000 after buying an additional 413,487 shares in the last quarter. Handelsbanken Fonder AB grew its position in shares of Itron by 21.2% during the 2nd quarter. Handelsbanken Fonder AB now owns 943,564 shares of the scientific and technical instruments company’s stock worth $124,201,000 after buying an additional 165,300 shares during the period. Finally, Amundi grew its position in shares of Itron by 18.4% during the 1st quarter. Amundi now owns 929,407 shares of the scientific and technical instruments company’s stock worth $97,313,000 after buying an additional 144,361 shares during the period. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ITRI. Argus reissued a “hold” rating on shares of Itron in a research note on Tuesday, November 4th. Oppenheimer set a $145.00 price objective on shares of Itron and gave the company an “outperform” rating in a report on Friday, October 31st. Robert W. Baird restated a “neutral” rating and issued a $118.00 target price (down from $137.00) on shares of Itron in a research note on Friday, October 31st. Wall Street Zen raised Itron from a “hold” rating to a “buy” rating in a research report on Saturday, November 1st. Finally, Baird R W downgraded Itron from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 31st. Nine analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, Itron presently has an average rating of “Moderate Buy” and an average price target of $139.00.

Itron Trading Up 0.8%

NASDAQ ITRI opened at $99.16 on Friday. The company has a current ratio of 2.17, a quick ratio of 1.91 and a debt-to-equity ratio of 0.46. The business has a fifty day simple moving average of $114.35 and a 200 day simple moving average of $121.59. Itron, Inc. has a 12 month low of $90.11 and a 12 month high of $142.00. The firm has a market capitalization of $4.54 billion, a P/E ratio of 17.83, a PEG ratio of 0.48 and a beta of 1.52.

Itron (NASDAQ:ITRI) last posted its earnings results on Thursday, October 30th. The scientific and technical instruments company reported $1.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.48 by $0.06. The firm had revenue of $581.63 million during the quarter, compared to analyst estimates of $578.49 million. Itron had a net margin of 10.69% and a return on equity of 17.82%. The business’s revenue was down 5.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.84 EPS. Itron has set its FY 2025 guidance at 6.840-6.940 EPS and its Q4 2025 guidance at 2.150-2.250 EPS. On average, analysts predict that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, SVP Christopher E. Ware sold 343 shares of the company’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $96.51, for a total value of $33,102.93. Following the completion of the transaction, the senior vice president directly owned 18,774 shares of the company’s stock, valued at $1,811,878.74. This represents a 1.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP John F. Marcolini sold 553 shares of the stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $96.51, for a total value of $53,370.03. Following the sale, the senior vice president directly owned 13,843 shares of the company’s stock, valued at $1,335,987.93. The trade was a 3.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 2,971 shares of company stock worth $286,731 in the last ninety days. 1.45% of the stock is owned by corporate insiders.

Itron Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.